View of experiment 1 with five-week old barley S42IL plants growing in The Plant Accelerator.

<p>View of experiment 1 with five-week old barley S42IL plants growing in The Plant Accelerator.</p

Additional file 1: of A qualitative study on barriers to evidence-based practice in patient counseling and advocacy in Germany

Key target organizations for the recruitment of patient counselors and representatives. (DOCX 14 kb

Development of shoot area of S42IL-121, Scarlett and S42IL-117 under well watered (solid line) and drought (dashed line) treatment, respectively.

<p>Development of shoot area of S42IL-121, Scarlett and S42IL-117 under well watered (solid line) and drought (dashed line) treatment, respectively.</p

List of evaluated traits.

a<p>Integral: calculated for length of entire experiment, respectively.</p>b<p>kilo Pixel.</p

List of 44QTL detected for 11 traits in the S42IL-population.

a<p>Trait abbreviations are given in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0097047#pone-0097047-t001" target="_blank">Table 1</a>.</p>b<p>By chromosome and cM position.</p>c<p>Treatment under which effect occured, a: main effect, d: under drought treatment, w: under well watered treatment.</p>d<p>LSMEANS Scarlett for the indicated trait and treatment.</p>e<p>LSMEANS for indicated IL for indicated trait and treatment, if under more than one treatment then a.</p>f<p>Deviation from Scarlett  =  LSMEANS[IL] - LSMEANS [Scarlett].</p>g<p>Deviation from Scarlett in %  =  (LSMEANS[IL] – LSMEANS [Scarlett])/LSMEANS[Scarlett] *100.</p>h<p>References: ¹ Laurie et al. (1995), ² Gottwald et al. (2004), ³ Wang et al. (2010)</p>i<p>I: Von Korff et al. (2006), II: Schmalenbach et al. (2009), III: Wang et al. (2010), IV: March et al. (in prep.), V: Honsdorf et al. (in prep.).</p

Barley plants at the weighing and watering unit after leaving the imaging station.

<p>Barley plants at the weighing and watering unit after leaving the imaging station.</p

sj-pdf-4-ict-10.1177_15347354231198474 – Supplemental material for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study

Supplemental material, sj-pdf-4-ict-10.1177_15347354231198474 for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study by Annika Mascher, Florian Pelzer, Lorna Jane Duncan, David Dominique Martin, Stephan Baumgartner and Bettina Berger in Integrative Cancer Therapies</p

sj-pdf-2-ict-10.1177_15347354231198474 – Supplemental material for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study

Supplemental material, sj-pdf-2-ict-10.1177_15347354231198474 for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study by Annika Mascher, Florian Pelzer, Lorna Jane Duncan, David Dominique Martin, Stephan Baumgartner and Bettina Berger in Integrative Cancer Therapies</p

sj-pdf-3-ict-10.1177_15347354231198474 – Supplemental material for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study

Supplemental material, sj-pdf-3-ict-10.1177_15347354231198474 for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study by Annika Mascher, Florian Pelzer, Lorna Jane Duncan, David Dominique Martin, Stephan Baumgartner and Bettina Berger in Integrative Cancer Therapies</p

sj-pdf-1-ict-10.1177_15347354231198474 – Supplemental material for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study

Supplemental material, sj-pdf-1-ict-10.1177_15347354231198474 for The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study by Annika Mascher, Florian Pelzer, Lorna Jane Duncan, David Dominique Martin, Stephan Baumgartner and Bettina Berger in Integrative Cancer Therapies</p